Searches , social queries for MULTIDRUG RESISTANT-TUBERCULOSIS

Search references for MULTIDRUG RESISTANT-TUBERCULOSIS. Phrases containing MULTIDRUG RESISTANT-TUBERCULOSIS

See searches and references containing MULTIDRUG RESISTANT-TUBERCULOSIS!

Searches containing MULTIDRUG RESISTANT-TUBERCULOSIS

MULTIDRUG RESISTANT-TUBERCULOSIS

  • Multidrug-resistant tuberculosis
  • Medical condition

    Multidrug-resistant tuberculosis (MDR-TB) is a form of tuberculosis (TB) infection caused by bacteria that are resistant to treatment with at least two

    Multidrug-resistant tuberculosis

    Multidrug-resistant tuberculosis

    Multidrug-resistant_tuberculosis

  • Management of tuberculosis
  • Disease treatment

    disease that is resistant to first line therapy (i.e., for extensively drug-resistant tuberculosis (XDR-TB) or multidrug-resistant tuberculosis (MDR-TB)).

    Management of tuberculosis

    Management of tuberculosis

    Management_of_tuberculosis

  • Mycobacterium tuberculosis
  • Bacterium that causes tuberculosis

    antibiotic or a change in titration of the drug. M. tuberculosis is considered to be multidrug-resistant (MDR TB) if it has developed drug resistance to both

    Mycobacterium tuberculosis

    Mycobacterium tuberculosis

    Mycobacterium_tuberculosis

  • Tuberculosis
  • Infectious disease

    growing phenomenon, which led to a higher incidence of multidrug-resistant tuberculosis. Tuberculosis has existed since antiquity. Skeletal remains show some

    Tuberculosis

    Tuberculosis

    Tuberculosis

  • Extensively drug-resistant tuberculosis
  • Tuberculosis that is resistant to the most effective drugs

    Extensively drug-resistant tuberculosis (XDR-TB) is a form of tuberculosis caused by bacteria that are resistant to some of the most effective anti-TB

    Extensively drug-resistant tuberculosis

    Extensively drug-resistant tuberculosis

    Extensively_drug-resistant_tuberculosis

  • Pott's disease
  • Tuberculosis of the spine

    symptoms of the disease. Cases of tuberculosis have been on the decline; however, infections of multidrug resistant tuberculosis have remained constant since

    Pott's disease

    Pott's disease

    Pott's_disease

  • Multidrug-resistant bacteria
  • Bacteria resistant to three or more classes of antimicrobial drugs

    Multidrug-resistant (MDR) bacteria are bacteria that are resistant to three or more classes of antimicrobial drugs, making them hard to treat. MDR bacteria

    Multidrug-resistant bacteria

    Multidrug-resistant bacteria

    Multidrug-resistant_bacteria

  • Latent tuberculosis
  • State of tuberculosis infection without symptoms

    2020-02-04. Retrieved 2012-09-25. "CDC | TB | Fact Sheets | Multidrug-Resistant Tuberculosis (MDR TB)". Cdc.gov. Archived from the original on 2015-10-03

    Latent tuberculosis

    Latent_tuberculosis

  • Bedaquiline
  • Medication used to treat tuberculosis

    for use in tuberculosis (TB) treatment, as part of a fast-track accelerated approval, for use only in cases of multidrug-resistant tuberculosis, and the

    Bedaquiline

    Bedaquiline

    Bedaquiline

  • History of tuberculosis
  • patients with multidrug-resistant strains (resistant to, at least, both rifampin and isoniazid). In response to the resurgence of tuberculosis, the World

    History of tuberculosis

    History of tuberculosis

    History_of_tuberculosis

  • Multiple drug resistance
  • Measure of microorganism drug resistance

    in 2011. Common multidrug-resistant organisms, typically bacteria, include: Vancomycin-Resistant Enterococci (VRE) Methicillin-resistant Staphylococcus

    Multiple drug resistance

    Multiple drug resistance

    Multiple_drug_resistance

  • Post-tuberculosis lung disease
  • Long term complication of tuberculosis

    multi-drug-resistant tuberculosis. Around 10 percent have lost more than half of their lung function. Delayed diagnosis of TB, multidrug-resistant tuberculosis,

    Post-tuberculosis lung disease

    Post-tuberculosis lung disease

    Post-tuberculosis_lung_disease

  • Totally drug-resistant tuberculosis
  • Tuberculosis that is resistant to more drugs than XDR-TB

    Extensively drug-resistant tuberculosis (XDR-TB) Multidrug-resistant tuberculosis (MDR-TB) "WHO | Drug-resistant TB: Totally drug-resistant TB FAQ". WHO.

    Totally drug-resistant tuberculosis

    Totally_drug-resistant_tuberculosis

  • Elimination of tuberculosis
  • Global health initiative

    worldwide, making it the highest burden country for both tuberculosis and multidrug-resistant tuberculosis. Matteelli, Alberto; Rendon, Adrian; Tiberi, Simon;

    Elimination of tuberculosis

    Elimination_of_tuberculosis

  • Delamanid
  • Chemical compound

    to treat tuberculosis. Specifically it is used, along with other antituberculosis medications, for active multidrug-resistant tuberculosis. It is taken

    Delamanid

    Delamanid

  • Tuberculosis vaccines
  • Vaccines to prevent tuberculosis

    Stefan H. E.; van der Werf, Tjip S. (2013-04-01). "Targeting multidrug-resistant tuberculosis (MDR-TB) by therapeutic vaccines". Medical Microbiology and

    Tuberculosis vaccines

    Tuberculosis_vaccines

  • Everything Is Tuberculosis
  • 2025 nonfiction book by John Green

    Cepheid to ease access to the tuberculosis treatment bedaquiline and rapid diagnostic testing for multidrug-resistant tuberculosis, respectively, which both

    Everything Is Tuberculosis

    Everything_Is_Tuberculosis

  • Jim Yong Kim
  • American physician (born 1959)

    Paul E, Kim JY. Community-based approaches to the control of multidrug-resistant tuberculosis: Introducing "DOTS-plus". British Medical Journal 1998; 317:671-4

    Jim Yong Kim

    Jim Yong Kim

    Jim_Yong_Kim

  • Amikacin
  • Antibiotic medication

    urinary tract infections. It is also used for the treatment of multidrug-resistant tuberculosis. It is used by injection into a vein using an IV or into a

    Amikacin

    Amikacin

    Amikacin

  • 2007 tuberculosis scare
  • International health scare

    tuberculosis scare occurred when a personal-injury lawyer from Atlanta, Andrew "Drew" Speaker, while infected with multidrug-resistant tuberculosis (MDR-TB)

    2007 tuberculosis scare

    2007_tuberculosis_scare

  • List of antibiotic-resistant bacteria
  • strains resistant to fluoroquinolone antibiotics, such as ciprofloxacin and levofloxacin, were also reported in North America in 2005. Multidrug-resistant Enterococcus

    List of antibiotic-resistant bacteria

    List of antibiotic-resistant bacteria

    List_of_antibiotic-resistant_bacteria

  • Partners In Health
  • Non-profit health care organization

    influenced national policies for prevention and treatment of multidrug-resistant tuberculosis and HIV and provides important training and support to help

    Partners In Health

    Partners In Health

    Partners_In_Health

  • Antimicrobial resistance
  • Resistance of microbes to drugs directed against them

    genetic mutations and the spread of resistant genes. Microbes resistant to multiple drugs are termed multidrug-resistant (MDR) and are sometimes called superbugs

    Antimicrobial resistance

    Antimicrobial resistance

    Antimicrobial_resistance

  • Cycloserine
  • Tuberculosis medication

    primarily for the treatment of multidrug-resistant (MDR-TB) and extensively drug-resistant (XDR-TB) strains of M. tuberculosis, remaining a second- or third-line

    Cycloserine

    Cycloserine

    Cycloserine

  • Linezolid
  • Antibiotic medication

    Brubakk O (February 2006). "Efficacy and safety of linezolid in multidrug resistant tuberculosis (MDR-TB)--a report of ten cases". The Journal of Infection

    Linezolid

    Linezolid

    Linezolid

  • Infection
  • Invasion of an organism's body by pathogenic agents

    7326/0003-4819-127-8_Part_1-199710150-00010. PMID 9341063. S2CID 20357515. Multidrug-Resistant "Tuberculosis". Centers for Disease Control and Prevention. Archived March

    Infection

    Infection

    Infection

  • Eugene Bell Foundation
  • U.S.-based nonprofit organization

    humanitarian assistance to rural North Korea. Focusing on multidrug-resistant tuberculosis, the foundation currently sponsors 12 treatment centers, drawing

    Eugene Bell Foundation

    Eugene_Bell_Foundation

  • Antibiotic
  • Antimicrobial substance active against bacteria

    challenges. Every year, nearly half a million new cases of multidrug-resistant tuberculosis (MDR-TB) are estimated to occur worldwide. For example, NDM-1

    Antibiotic

    Antibiotic

    Antibiotic

  • Ethionamide
  • Chemical compound

    to treat tuberculosis. Specifically it is used, along with other antituberculosis medications, to treat active multidrug-resistant tuberculosis. It is no

    Ethionamide

    Ethionamide

    Ethionamide

  • Koen Andries
  • Belgian scientist

    ATP-synthase of Mycobacterium tuberculosis, Science 307 (5707): 223–27 Invention: Drug against multidrug-resistant tuberculosis Koen Andries (University of

    Koen Andries

    Koen_Andries

  • Ofloxacin
  • Antibiotic to treat bacterial infections

    Other uses, along with other medications, include treating multidrug resistant tuberculosis. An eye drop may be used for a superficial bacterial infection

    Ofloxacin

    Ofloxacin

    Ofloxacin

  • Globalization and disease
  • of bacteria. Antibiotic-resistant TB is also known as "multidrug-resistant tuberculosis." "Multidrug-resistant tuberculosis" is a pandemic that is on

    Globalization and disease

    Globalization and disease

    Globalization_and_disease

  • Tuberculosis in China
  • estimated total of new cases, and multidrug-resistant tuberculosis was a major problem. These signs of inadequate tuberculosis control can be linked to a malfunctioning

    Tuberculosis in China

    Tuberculosis in China

    Tuberculosis_in_China

  • Trimethoprim/sulfamethoxazole
  • Combination of two antibiotic drugs

    (August 2013). "Evaluation of co-trimoxazole in the treatment of multidrug-resistant tuberculosis". The European Respiratory Journal. 42 (2): 504–512. doi:10

    Trimethoprim/sulfamethoxazole

    Trimethoprim/sulfamethoxazole

    Trimethoprim/sulfamethoxazole

  • 4-Aminosalicylic acid
  • Anti-tuberculosis and anti-inflammatory drug

    streptomycin) for treating tuberculosis and its cost is higher, but it is still useful in the treatment of multidrug-resistant tuberculosis. PAS is always used

    4-Aminosalicylic acid

    4-Aminosalicylic acid

    4-Aminosalicylic_acid

  • Patricia Sheen
  • Peruvian biologist

    development and enhancement of diagnostic methods for tuberculosis and multidrug-resistant tuberculosis. In 2014, she was awarded the National L'Oréal-Unesco-Concytec

    Patricia Sheen

    Patricia Sheen

    Patricia_Sheen

  • Vasant Narasimhan
  • American doctor and CEO

    malaria and HIV/AIDS in Tanzania and he did his thesis on multidrug resistant tuberculosis in Peru. Narasimhan joined McKinsey & Co, as a consultant and

    Vasant Narasimhan

    Vasant Narasimhan

    Vasant_Narasimhan

  • Kanamycin A
  • Antibiotic

    is very concerning for its use in treating multidrug-resistant tuberculosis and other multidrug-resistant Gram-negative bacterial infections. This is

    Kanamycin A

    Kanamycin A

    Kanamycin_A

  • Francis Drobniewski
  • British microbiologist

    of tuberculosis (TB) and other respiratory infections, including multidrug-resistant forms and their implications for treatment and public health. He

    Francis Drobniewski

    Francis_Drobniewski

  • Zarir Udwadia
  • Indian pulmonologist

    pulmonologist and researcher. His work on drug resistant tuberculosis has led to improvements in India's National Tuberculosis Control Programme. Udwadia was the

    Zarir Udwadia

    Zarir_Udwadia

  • N95 respirator
  • Particulate respirator meeting the N95 standard

    along with chemical cartridge requirements. In 1992, the multidrug-resistant tuberculosis task force within the CDC was tasked with reducing the incidences

    N95 respirator

    N95 respirator

    N95_respirator

  • Pyrazinamide
  • Medication

    with multidrug-resistant tuberculosis. M. bovis is innately resistant due to a H57D difference in pncA (when compared to the version of M. tuberculosis).

    Pyrazinamide

    Pyrazinamide

    Pyrazinamide

  • Gail H. Cassell
  • American microbiologist

    microbiologist whose research focuses on Mycoplasma species and multidrug-resistant tuberculosis. She is vice president of TB drug development at the Infectious

    Gail H. Cassell

    Gail_H._Cassell

  • Pneumococcal infection
  • Medical condition

    levofloxacin-non-susceptible Streptococcus pneumoniae and treatment for multidrug-resistant tuberculosis in children in South Africa: a cohort observational surveillance

    Pneumococcal infection

    Pneumococcal_infection

  • Pandemic
  • Widespread, often global, epidemic of severe infectious disease

    professionals. Every year, nearly half a million new cases of multidrug-resistant tuberculosis (MDR-TB) are estimated to occur worldwide. China and India

    Pandemic

    Pandemic

    Pandemic

  • Chronic meningitis
  • Inflammation of membranes around the brain

    in tuberculosis meningitis. HIV co-infection, multidrug resistant tuberculosis, or the development of hydrocephalus or focal weakness in tuberculosis meningitis

    Chronic meningitis

    Chronic meningitis

    Chronic_meningitis

  • Gates Foundation
  • Private foundation founded by Bill and Melinda Gates

    strain is resistant to the bactericidal antibiotic rifampicin, a widely accepted indicator of the presence of multidrug resistant tuberculosis. Visceral

    Gates Foundation

    Gates Foundation

    Gates_Foundation

  • Pretomanid
  • Chemical compound

    treatment of pulmonary extensively drug resistant, or treatment-intolerant or nonresponsive multidrug-resistant tuberculosis. Pretomanid is activated in the mycobacterium

    Pretomanid

    Pretomanid

    Pretomanid

  • Timeline of the 19th century
  • Cengage Learning. ISBN 978-1-133-31272-7. OCLC 890080129. "Multidrug-Resistant Tuberculosis". Centers for Disease Control and Prevention. Archived from

    Timeline of the 19th century

    Timeline of the 19th century

    Timeline_of_the_19th_century

  • François Balloux
  • Professor of Computational Biology at UCL

    "Impact of HIV co-infection on the evolution and transmission of multidrug-resistant tuberculosis". eLife. 5 e16644. doi:10.7554/eLife.16644. ISSN 2050-084X

    François Balloux

    François Balloux

    François_Balloux

  • Emerging infectious disease
  • New or rapidly increasing disease

    bioterrorism potential, CDC category C (least dangerous): Influenza Multidrug-resistant tuberculosis (MDR-TB) Nipah virus Rabies SARS coronavirus Tick-borne encephalitis

    Emerging infectious disease

    Emerging infectious disease

    Emerging_infectious_disease

  • Culture conversion
  • Medical diagnostic method

    recovering from, tuberculosis.[citation needed] Brust, J. (6 Jan 2011). "Culture Conversion Among HIV Co-Infected Multidrug-Resistant Tuberculosis Patients in

    Culture conversion

    Culture_conversion

  • 19th century
  • One hundred years, from 1801 to 1900

    Archived from the original on 2010-01-04. Retrieved 2008-03-03. "Multidrug-Resistant Tuberculosis". Centers for Disease Control and Prevention. 2018-12-31. Archived

    19th century

    19th century

    19th_century

  • GeneXpert MTB/RIF
  • Tuberculosis disgnostic and antibiotic sensitivity test

    rapid tuberculosis diagnosis and rapid antibiotic sensitivity test. It is an automated diagnostic test that can identify Mycobacterium tuberculosis (MTB)

    GeneXpert MTB/RIF

    GeneXpert MTB/RIF

    GeneXpert_MTB/RIF

  • Rifampicin
  • Antibiotic medication

    first-line antitubercular drugs. Early detection of such multidrug or extensively drug-resistant tuberculosis is critical in improving patient outcomes by instituting

    Rifampicin

    Rifampicin

    Rifampicin

  • WHO Model List of Essential Medicines
  • Formulary by the World Health Organization

    Terizidone is an alternative Prothionamide is an alternative for multidrug-resistant tuberculosis Imipenem/cilastatin is an alternative For treatment of chronic

    WHO Model List of Essential Medicines

    WHO_Model_List_of_Essential_Medicines

  • List of causes of death by rate
  • and tuberculosis 50.5 6.85% −24.5 Tuberculosis 14.9 2.02% −31.4 Drug-susceptible tuberculosis 13.2 1.79% −31.9 Multidrug-resistant tuberculosis without

    List of causes of death by rate

    List of causes of death by rate

    List_of_causes_of_death_by_rate

  • Antibiotic use in livestock
  • Use of antibiotics for any purpose in the husbandry of livestock

    people die each year from drug-resistant infections, including approximately 230,000 deaths from multidrug-resistant tuberculosis. In addition to the health

    Antibiotic use in livestock

    Antibiotic use in livestock

    Antibiotic_use_in_livestock

  • Burkholderia gladioli
  • Species of bacterium

    M. tuberculosis isolates, suggesting that it may be a useful starting point in developing new antibiotics to treat multidrug resistant tuberculosis infections

    Burkholderia gladioli

    Burkholderia_gladioli

  • Mycobacteria growth indicator tube
  • Bacteriology medium

    Automated BACTEC MGIT 960 System for Testing Susceptibility of Mycobacterium tuberculosis to Four Major Antituberculous Drugs: Comparison with the Radiometric

    Mycobacteria growth indicator tube

    Mycobacteria growth indicator tube

    Mycobacteria_growth_indicator_tube

  • Tom Frieden
  • American physician

    by nearly half and cutting multidrug-resistant tuberculosis by 80 percent. The city's program became a model for tuberculosis control nationally and globally

    Tom Frieden

    Tom Frieden

    Tom_Frieden

  • Mountains Beyond Mountains
  • 2003 book by Tracy Kidder

    continued to work for PIH. PART III: Médicos Aventureros In 1995, multidrug-resistant tuberculosis (MDR TB) claimed the life of a close friend known as Father

    Mountains Beyond Mountains

    Mountains_Beyond_Mountains

  • Endobronchial valve
  • Complementary Approach to Treat Cavities in Multidrug-Resistant Tuberculosis and Difficult-to-Treat Tuberculosis: A Case Series". Respiration. 92 (5): 316–328

    Endobronchial valve

    Endobronchial valve

    Endobronchial_valve

  • Health in China
  • estimated total of new cases, and multidrug-resistant tuberculosis was a major problem. These signs of inadequate tuberculosis control can be linked to a malfunctioning

    Health in China

    Health in China

    Health_in_China

  • Jaime Bayona
  • Peruvian physician

    Partners in Health (PIH) that started in Lima, Peru, to treat multidrug-resistant tuberculosis (MDR-TB) and HIV/AIDS in patients, and to provide health care

    Jaime Bayona

    Jaime_Bayona

  • Dr. D. Y. Patil Medical College, Hospital & Research Centre
  • Hospital in Pune, Maharashtra, India

    offers practical recommendations to enhance tuberculosis care (TB) and multidrug-resistant tuberculosis (MDR-TB). A Bachelor of Medicine and Bachelor

    Dr. D. Y. Patil Medical College, Hospital & Research Centre

    Dr. D. Y. Patil Medical College, Hospital & Research Centre

    Dr._D._Y._Patil_Medical_College,_Hospital_&_Research_Centre

  • Operation ASHA
  • is to detect and cure TB, as well as to prevent and treat multidrug-resistant tuberculosis (MDR-TB) in India and Cambodia. Operation ASHA specializes

    Operation ASHA

    Operation_ASHA

  • Botšabelo Hospital
  • Hospital in Maseru, Lesotho

    with Multidrug-resistant tuberculosis exclusively. As of 2020, it was the only hospital in the country accredited to provide comprehensive tuberculosis drug

    Botšabelo Hospital

    Botšabelo_Hospital

  • Epidemic Intelligence Service
  • U.S. Centers for Disease Control and Prevention program

    Belongia, C.W. Hedberg, G.J. Gleich, et al. 1992 An Outbreak of Multidrug-Resistant Tuberculosis Among Hospitalized Patients with the Acquired Immunodeficiency

    Epidemic Intelligence Service

    Epidemic Intelligence Service

    Epidemic_Intelligence_Service

  • Drug resistance
  • Pathogen resistance to medications

    and drive research. When an organism is resistant to more than one drug, it is said to be multidrug-resistant. The development of antibiotic resistance

    Drug resistance

    Drug resistance

    Drug_resistance

  • TB Alliance
  • Medical non-profit for tuberculosis

    societies. The cost of treating a single case of multidrug-resistant TB (MDR-TB) or extensively drug-resistant TB (XDR-TB) can be thousands of times more expensive

    TB Alliance

    TB_Alliance

  • Keertan Dheda
  • High Incidence of Hospital Admissions with Multidrug Resistant and Extensively Drug Resistant Tuberculosis among South African Health Care Workers. Ann

    Keertan Dheda

    Keertan Dheda

    Keertan_Dheda

  • Prisons in Russia
  • Prison system in Russia

    Barriers to successful tuberculosis treatment in Tomsk, Russian Federation: non-adherence, default and the acquisition of multidrug resistance. Bulletin

    Prisons in Russia

    Prisons in Russia

    Prisons_in_Russia

  • Mbuji-Mayi
  • Provincial capital and city in Kasai-Oriental, Democratic Republic of the Congo

    Bouke C.; Boelaert, Marleen (2018). "Outbreak of Tuberculosis and Multidrug-Resistant Tuberculosis, Mbuji-Mayi Central Prison, Democratic Republic of

    Mbuji-Mayi

    Mbuji-Mayi

    Mbuji-Mayi

  • Threonine
  • Amino acid

    function, immunological response and gut flora. With multidrug-resistant Mycobacterium tuberculosis (TB) remaining a public health crisis with a total of

    Threonine

    Threonine

    Threonine

  • Mycolic acid
  • Long fatty acids found in the cell walls of the Mycobacteriales taxon

    ; Geiter, L. J.; Wells, C. D. (2012). "Delamanid for Multidrug-Resistant Pulmonary Tuberculosis". New England Journal of Medicine. 366 (23): 2151–2160

    Mycolic acid

    Mycolic_acid

  • Gladiolin
  • Chemical compound

    Ruesch-Gerdes, Sabine; Lange, Christoph (November 2008). "Multidrug- and Extensively Drug-Resistant Tuberculosis, Germany". Emerging Infectious Diseases. 14 (11):

    Gladiolin

    Gladiolin

  • Transmission-based precautions
  • Infection-control precautions in health care

    application of contact precautions for patients infected or colonized with Multidrug-Resistant Organisms MDROs is described in the 2006 HICPAC/CDC MDRO guideline

    Transmission-based precautions

    Transmission-based_precautions

  • Health in Namibia
  • drug‑sensitive TB. Despite this progress, multidrug‑resistant tuberculosis (MDR‑TB) and extensively drug‑resistant tuberculosis (XDR‑TB) are of major concern, with

    Health in Namibia

    Health_in_Namibia

  • HIV/AIDS in Lesotho
  • Castro, Kenneth G.; Weyer, Karin (2007). "HIV Infection and Multidrug-Resistant Tuberculosis: The Perfect Storm". The Journal of Infectious Diseases. 196:

    HIV/AIDS in Lesotho

    HIV/AIDS in Lesotho

    HIV/AIDS_in_Lesotho

  • WHO Model List of Essential Medicines for Children
  • Formulary

    combination with meropenem Prothionamide is an alternative for multidrug-resistant tuberculosis Imipenem/cilastatin is an alternative For treatment of chronic

    WHO Model List of Essential Medicines for Children

    WHO_Model_List_of_Essential_Medicines_for_Children

  • Klebsiella pneumoniae
  • Species of bacterium

    Infections due to multidrug-resistant gram-negative pathogens in the ICU have invoked the re-emergence of colistin. However, colistin-resistant strains of K

    Klebsiella pneumoniae

    Klebsiella pneumoniae

    Klebsiella_pneumoniae

  • Peptidoglycan recognition protein
  • Protein family

    "Serum sCD14, PGLYRP2 and FGA as potential biomarkers for multidrug-resistant tuberculosis based on data-independent acquisition and targeted proteomics"

    Peptidoglycan recognition protein

    Peptidoglycan recognition protein

    Peptidoglycan_recognition_protein

  • Megan B. Murray
  • American epidemiologist

    develop a mathematical model that proved that a number of multidrug-resistant strains of tuberculosis can easily reproduce and spread. She also worked with

    Megan B. Murray

    Megan_B._Murray

  • Pneumonia
  • Inflammation of the alveoli of the lungs

    with healthcare-associated pneumonia, it is less likely to involve multidrug-resistant bacteria. Although the latter are no longer rare in CAP, they are

    Pneumonia

    Pneumonia

    Pneumonia

  • Carbapenem
  • Class of highly effective antibiotic agents

    class of antibiotics is usually reserved for known or suspected multidrug-resistant (MDR) bacterial infections. Similar to penicillins and cephalosporins

    Carbapenem

    Carbapenem

    Carbapenem

  • Typhoid fever
  • Disease caused by the bacteria Salmonella typhi

    first-line treatment of typhoid fever. Typhoid resistant to these agents is known as multidrug-resistant typhoid. Ciprofloxacin resistance is an increasing

    Typhoid fever

    Typhoid_fever

  • Access to medicines
  • for the Treatment of Multidrug-Resistant Tuberculosis in 134 Low- and Middle-Income Countries". JnJ. 29 September 2023. "Tuberculosis Advocates Push For

    Access to medicines

    Access_to_medicines

  • Tebipenem pivoxil
  • Chemical compound

    "Pharmacodynamics of Tebipenem: New Options for Oral Treatment of Multidrug-Resistant Gram-Negative Infections". Antimicrobial Agents and Chemotherapy

    Tebipenem pivoxil

    Tebipenem pivoxil

    Tebipenem_pivoxil

  • Novosibirsk TB Research Institute
  • role of surgery in the treatment of pulmonary TB and multidrug- and extensively drug-resistant TB. WHO: Geneva 2014. p.8 Collaborating Centre WHO-NTRI

    Novosibirsk TB Research Institute

    Novosibirsk_TB_Research_Institute

  • Source attribution
  • Epidemiology method

    "Impact of HIV co-infection on the evolution and transmission of multidrug-resistant tuberculosis". eLife. 5. doi:10.7554/eLife.16644. PMC 4978521. PMID 27502557

    Source attribution

    Source_attribution

  • 2014 in the Philippines
  • services. March 28 – In a report presented by DOH, cases of multidrug resistant Tuberculosis (MDR-TB) increased to 10,000 cases in Northern Mindanao. April

    2014 in the Philippines

    2014_in_the_Philippines

  • MTBVAC
  • Tuberculosis vaccine candidate

    (January 2001). "High rate of tuberculosis reinfection during a nosocomial outbreak of multidrug-resistant tuberculosis caused by Mycobacterium bovis

    MTBVAC

    MTBVAC

  • Hospital-acquired infection
  • Infection spread in hospitals or health care facilities

    staff to adequately control the spread of infections. Moreover, multidrug-resistant infections can leave the hospital and become part of the community

    Hospital-acquired infection

    Hospital-acquired infection

    Hospital-acquired_infection

  • Tumani Corrah
  • Gambian clinician

    "Whole-genome sequencing illuminates the evolution and spread of multidrug-resistant tuberculosis in Southwest Nigeria". PLOS ONE. 12 (9) e0184510. Bibcode:2017PLoSO

    Tumani Corrah

    Tumani Corrah

    Tumani_Corrah

  • Pacific Health Summit
  • Newborn Health 2009: The Global Nutrition Challenge 2008: Multidrug-resistant Tuberculosis 2007: Pandemics 2006: Early Health 2005: Science, Innovation

    Pacific Health Summit

    Pacific_Health_Summit

  • Health in the Federated States of Micronesia
  • well as a high rate of tuberculosis, which is present on all the islands. Twenty-one cases of multidrug-resistant tuberculosis were detected in Chuuk

    Health in the Federated States of Micronesia

    Health in the Federated States of Micronesia

    Health_in_the_Federated_States_of_Micronesia

  • Mycobacterium leprae
  • Bacterium that causes leprosy

    1960s, it has developed resistance against this antibiotic. Currently, a multidrug treatment (MDT) is recommended by the World Health Organization, including

    Mycobacterium leprae

    Mycobacterium leprae

    Mycobacterium_leprae

  • Lorna Thorpe
  • American epidemiologist

    Wells (2005). "Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study". The Lancet. 365 (9456):

    Lorna Thorpe

    Lorna_Thorpe

  • Joia Mukherjee
  • American public health doctor

    Health Organization Green Light Committee on the Treatment of Multidrug Resistant Tuberculosis, the Infectious Disease Society of America Committee on International

    Joia Mukherjee

    Joia Mukherjee

    Joia_Mukherjee

Searches for online references containing MULTIDRUG RESISTANT-TUBERCULOSIS

MULTIDRUG RESISTANT-TUBERCULOSIS

Search references containing MULTIDRUG RESISTANT-TUBERCULOSIS

MULTIDRUG RESISTANT-TUBERCULOSIS

Search queries for Facebook and twitter posts, hashtags with MULTIDRUG RESISTANT-TUBERCULOSIS

MULTIDRUG RESISTANT-TUBERCULOSIS

Follow users with usernames @MULTIDRUG RESISTANT-TUBERCULOSIS or posting hashtags containing #MULTIDRUG RESISTANT-TUBERCULOSIS

MULTIDRUG RESISTANT-TUBERCULOSIS

Online names & meanings

Search queries for Facebook and twitter users, user names, hashtags with MULTIDRUG RESISTANT-TUBERCULOSIS

MULTIDRUG RESISTANT-TUBERCULOSIS

Top search, Social media, medium, facebook & news articles containing MULTIDRUG RESISTANT-TUBERCULOSIS

MULTIDRUG RESISTANT-TUBERCULOSIS

Searches for Acronyms & meanings containing MULTIDRUG RESISTANT-TUBERCULOSIS

MULTIDRUG RESISTANT-TUBERCULOSIS

Searches, Indeed job searches and job offers containing MULTIDRUG RESISTANT-TUBERCULOSIS

Other words and meanings similar to

MULTIDRUG RESISTANT-TUBERCULOSIS

Search in online dictionary sources & meanings containing MULTIDRUG RESISTANT-TUBERCULOSIS

MULTIDRUG RESISTANT-TUBERCULOSIS